Shingles Vaccine Cut Dementia Risk 24% in 500,000 Older Adults, Extending Earlier 20% Signal
Updated
Updated · Leader Publications · Aug 24
Shingles Vaccine Cut Dementia Risk 24% in 500,000 Older Adults, Extending Earlier 20% Signal
3 articles · Updated · Leader Publications · Aug 24
Summary
More than 500,000 older adults in skilled nursing facilities who got a shingles vaccine showed a 24% lower dementia risk over four years, according to a new Annals of Internal Medicine study.
Researchers say the effect could stem from preventing repeated shingles-virus reactivations that may inflame brain tissue, damage cerebral blood vessels and worsen chronic immune-driven inflammation tied to cognitive decline.
The finding adds to a 2025 Nature study in Wales, where a birthday-based vaccine cutoff created a natural experiment and vaccine-eligible adults had a 20% lower dementia diagnosis rate over seven years.
A separate Kaiser Permanente analysis of 300,000-plus adults linked the newer Shingrix shot to a 51% lower dementia risk, though all of the evidence so far is observational rather than from randomized trials.
With similar signals now appearing across countries and high-risk populations, researchers are calling for clinical trials; the vaccine is already recommended for adults 50 and older.
Why did a massive English study find zero dementia benefits from the shingles vaccine while neighboring Wales reported a dramatic drop?
Could common vaccines like the flu or shingles shot secretly rewire your brain's immune system to fight off dementia?
Shingles Vaccination Reduces Dementia Risk by Up to 50%: Landmark Studies, Mechanisms, and Public Health Implications
Overview
Recent large-scale studies show that shingles vaccination, especially with the newer Shingrix vaccine, is linked to a significant reduction in dementia risk among older adults. This protection is even stronger in women, likely due to their naturally stronger immune responses. The vaccine works by preventing the reactivation of the varicella-zoster virus, which can cause harmful inflammation and trigger amyloid buildup in the brain—a key feature of Alzheimer’s disease. Additionally, routine vaccines like flu and pneumonia shots also lower dementia risk, partly by reducing vascular problems such as stroke. These findings suggest that vaccines may help protect brain health through both direct and broad immune benefits.